全文获取类型
收费全文 | 7413篇 |
免费 | 467篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 130篇 |
儿科学 | 245篇 |
妇产科学 | 219篇 |
基础医学 | 1146篇 |
口腔科学 | 313篇 |
临床医学 | 687篇 |
内科学 | 1227篇 |
皮肤病学 | 141篇 |
神经病学 | 887篇 |
特种医学 | 263篇 |
外科学 | 983篇 |
综合类 | 22篇 |
一般理论 | 1篇 |
预防医学 | 599篇 |
眼科学 | 74篇 |
药学 | 493篇 |
中国医学 | 6篇 |
肿瘤学 | 458篇 |
出版年
2023年 | 25篇 |
2022年 | 59篇 |
2021年 | 81篇 |
2020年 | 79篇 |
2019年 | 96篇 |
2018年 | 118篇 |
2017年 | 106篇 |
2016年 | 122篇 |
2015年 | 109篇 |
2014年 | 165篇 |
2013年 | 282篇 |
2012年 | 398篇 |
2011年 | 384篇 |
2010年 | 215篇 |
2009年 | 219篇 |
2008年 | 407篇 |
2007年 | 374篇 |
2006年 | 368篇 |
2005年 | 368篇 |
2004年 | 352篇 |
2003年 | 347篇 |
2002年 | 307篇 |
2001年 | 298篇 |
2000年 | 326篇 |
1999年 | 292篇 |
1998年 | 90篇 |
1997年 | 82篇 |
1996年 | 73篇 |
1995年 | 54篇 |
1994年 | 80篇 |
1993年 | 57篇 |
1992年 | 182篇 |
1991年 | 135篇 |
1990年 | 121篇 |
1989年 | 102篇 |
1988年 | 103篇 |
1987年 | 114篇 |
1986年 | 86篇 |
1985年 | 93篇 |
1984年 | 98篇 |
1983年 | 67篇 |
1982年 | 49篇 |
1981年 | 31篇 |
1980年 | 39篇 |
1979年 | 56篇 |
1978年 | 45篇 |
1977年 | 42篇 |
1975年 | 23篇 |
1973年 | 23篇 |
1972年 | 25篇 |
排序方式: 共有7894条查询结果,搜索用时 15 毫秒
1.
Methicillin‐resistant Staphylococcus aureus eradication in young infants should include the diaper area and treat housing contacts 下载免费PDF全文
2.
J Syrj?nen M Iivanainen M Kallio H Somer V V Valtonen 《Annals of clinical research》1986,18(4):191-194
Three different pathogenic mechanisms are apparent for paraparesis in association with a bacterial infection: a spinal cord compression caused by either an epidural abscess or a vertebral collapse due to spondylitis, an ischaemic spinal cord lesion as a result of septic thromboembolus in abdominal aorta, and a nonspecific, probably immunological, cause in association with reactive polyarthritis. An example of each of these mechanisms is described by means of case histories. 相似文献
3.
At our center, since 1982, a body mass index (BMI) of less than 30 has been a prerequisite for placing a patient on the waiting
list for renal transplantation. This decision was made because obese transplant recipients seemed to have a less than favorable
post-transplant outcome. The aim of this study was to evaluate whether this requirement is still justified. Forty-six patients
with a BMI above 30 underwent primary cadaveric renal transplantation between 1972 and 1993. For each of these obese patients,
five consecutive non-obese (BMI 20–25) control patients were selected. Patient and graft survival, causes of graft loss, and
acute rejection rate were evaluated for the two patient groups before and after the year 1982. Within the first 30 post-transplant
days, one patient (2 %) and 11 grafts (24 %) were lost in the group of obese patients whereas seven patients (3 %) and 36
grafts (16 %) were lost in the control group. Among the obese patients, renal circulatory complications were a major cause
of graft loss. In the period 1973–1981, the 1-year patient survival rate was 65 % among obese patients versus 75 % among controls
from 1982 to 1993, this was 90 % versus 93 %. From 1973 to 1981, the 1-year graft survival rate was 25 % among obese patients
versus 53 % among controls (P < 0.05); from 1982 to 1993, it was 68 % versus 84 % (P = NS). Multivariate analysis showed that the immunosuppressive regimen,
age of the patient, BMI, and cold ischemia time of the graft had a significant influence on graft survival. The acute rejection
rate within the first 30 days was 28 % among obese patients and 35 % among controls (P = NS). We conclude that a BMI below
or equal to 30 is still justified as a prerequisite for placement on the waiting list for renal transplantation, for despite
an overall improvement, the outcome of renal transplantation in obese patients remains worse than that in non-obese patients.
Received: 3 February 1997 Received after revision: 4 April 1997 Accepted: 8 April 1997 相似文献
4.
5.
6.
The applicability of the ICD E code as a causal indicator of nonfatal injuries has been criticized. New codes have been developed to replace the ICD codes. We compared the coding reliability of the ICD E and place vs. the Nordic mechanism (M) and place codes. The mean accuracy (76 vs. 70%) (p less than 0.002) and the intercoder reliability (84 vs. 69%) (p less than 0.001) were better for the E than M code. The accuracy of the place codes was the same (83%). A short training improved (p less than 0.001) the accuracy of all four codes. The replacement of the E code with the M code would not improve the reliability of data on causes of injuries. 相似文献
7.
The KID-syndrome in Finland. A report of four cases 总被引:2,自引:0,他引:2
K Tuppurainen J Fr?ki S Karjalainen L Palj?rvi R Suhonen M Ryyn?nen 《Acta ophthalmologica》1988,66(6):692-698
We describe a rare syndrome in a Finnish family, in which the father and his two sons are congenitally deaf and also exhibit corneal vascularization, and hyperkeratosis of the skin of the palms, soles, elbows and knees. In addition, all 3 suffer from fungal infections of the skin and nails. We also describe a fourth, sporadic case of a 9-year-old girl with the same disease. The KID (k = keratitis, i = ichthyosis, d = deafness) syndrome is an ectodermal dysplasia that probably arises through mutation, and is transmitted as an autosomal dominant in the family described by us. 相似文献
8.
Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. 总被引:1,自引:0,他引:1
M I Uusitupa L Mykk?nen O Siitonen M Laakso H Sarlund P Kolehmainen T R?s?nen J Kumpulainen K Py?r?l? 《The British journal of nutrition》1992,68(1):209-216
Altogether twenty-six elderly subjects (aged 65-74 years) with persistent impaired glucose tolerance (World Health Organization (1985) criteria) identified in a population-based study, were randomly treated either with chromium-rich yeast (160 micrograms Cr/d) or with placebo for 6 months. The 24 h urinary Cr increased from 0.13 (SE 0.03) to 0.40 (SE 0.06) micrograms/d in the Cr group (n 13) but no change was found in the placebo group (n 11) (0.13 (SE 0.02) v. 0.11 (SE 0.02) micrograms/d). No significant change was observed in the oral glucose tolerance test (glucose dose 75 g; 0, 1 and 2 h blood glucose respectively): 5.3 (SE 0.1), 9.3 (SE 0.3), 8.2 (SE 0.3) mmol/l v. 5.0 (SE 0.1), 8.5 (SE 0.4), 7.3(SE 0.5) mmol/l in the Cr group; 4.9 (SE 0.2), 9.2 (SE 0.6), 8.1 (SE 0.3) mmol/l v. 4.8 (SE 0.2), 8.5 (SE 0.5), 7.0 (SE 0.6) mmol/l in the placebo group (baseline v. 6 months). Glycosylated haemoglobin, plasma insulin, C-peptide and apolipoprotein A1 and B levels remained unchanged, and no improvement was seen in serum total cholesterol (6.2 (SE 0.3) v. 6.4 (SE 0.3) mmol/l for the Cr group, 6.2 (SE 0.4) v. 6.5 (SE 0.3) mmol/l for the placebo group), high-density-lipoprotein-cholesterol (1.1 (SE 0.1) v. 1.2 (SE 0.1) mmol/l for the Cr group, 1.0 (SE 0.1) v. 1.1 (SE 0.1) mmol/l for the placebo group) or triacylglycerols (2.5 (SE 0.4) v. 2.0 (SE 0.4) mmol/l for the Cr group, 2.4 (SE 0.2) v. 2.5 (SE 0.2) mmol/l for the placebo group). The present results indicate that Cr supplementation does not improve glucose tolerance or serum lipid levels in elderly subjects with stable impaired glucose tolerance. 相似文献
9.
We analyzed clinical and radiographic long-term results in 96 patients (106 hips) with Perthes' disease 35 years after nonoperative treatment. 19 hips in 17 patients had early radiographic signs indicating atypically severe course of the disease and poor prognosis. None of them was radiographically good at skeletal maturity; 2 cases were fair and 17 poor. At the final follow-up 12 hips had radiographic arthrosis. 相似文献
10.
H. Komulainen S. -L. Vaittinen T. Vartiainen S. Ltjnen P. Paronen J. Tuomisto 《Basic & clinical pharmacology & toxicology》1992,70(6):424-428
Abstract: The pharmacokinetics of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) was evaluated after a single oral or intravenous administration in the rats using 14C-labelled compound. Twenty to 35% of the dose was absorbed into circulation from the gastrointestinal tract as assessed from the excretion in urine. The mean elimination half-life of the radioactivity in blood (T1/2 k10) was 3.8 hr. Traces of radioactivity remained in the blood for several days. The tissues lining the gastrointestinal and urinary tract, kidneys, stomach, small intestines and urinary bladder contained the highest radioactivity. The activity declined slowest in the kidneys. Urine was the main excretion route. Seventy-seven % of the total amount excreted appeared in urine in 12 hr and 90% in 24 hr. No radioactivity was exhaled in air suggesting that elimination through respiration did not occur. After an intravenous administration of 14C-MX, the T1/2 k10, was much longer, 22.9 hr, and the total elimination half-life (T1/2 β), 42.1 hr. The results indicate that MX is absorbed from the gastrointestinal tract to a considerable degree and it is excreted in urine very rapidly. A fraction of MX or its metabolites is retained in blood for a longer period of time. The pharmacokinetics of MX does not suggest extensive cumulation of MX in tissues after continuous exposure. 相似文献